id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0545-0005,FDA,FDA-2009-N-0545,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Publication,2023-05-04T04:00:00Z,2023,5,2023-05-04T04:00:00Z,,2023-05-04T13:46:01Z,2023-09401,0,0,09000064859cab3c
FDA-2009-N-0545-0004,FDA,FDA-2009-N-0545,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing",Notice,30 Day Proposed Information Collection,2023-01-06T05:00:00Z,2023,1,2023-01-06T05:00:00Z,,2023-01-06T14:57:53Z,2023-00013,0,0,090000648559b211